Fresenius agrees two acquisitions to expand Kabi drugs unit
The German healthcare group says the acquisitions will accelerate strategic growth in biopharmaceuticals and MedTech
Fresenius’ generic drugs unit Kabi has agreed to acquire infusion therapy maker Ivenix Inc and buy a majority stake in the mAbxience division of Spain's Insud Pharma, who make affordable biosimilar versions of cancer drugs.
Fresenius Kabi will acquire Ivenix for $240 million upfront, plus milestone payments contingent on commercial and operating targets, and mAbxience for $553 million plus milestone payments.
Fresenius Kabi says the acquisitions are part of a wider growth strategy where the company’s presence is enhanced in the biopharmaceuticals and MedTech markets. The company also hopes Ivenix will transform its product offering.
Ivenix, a US-based company, received US Food and Drug Administration approval for its infusion system and accompanying software in 2019, which Kabi will combine with its offering of intravenous fluids and infusion devices.
Commenting on the Ivenix acquisition, Fresenius Kabi CEO Michael Sen it would “complement and strengthen our existing infusion therapy offering” and allow the company to “create a superior portfolio for the US market”.
Sen added that buying a majority stake in mAbxience is expected to be a “highly complementary transaction in terms of biologics pipeline, manufacturing capabilities and the business model”.
“mAbxience and Ivenix as portfolio advancements are good for patients, good for healthcare providers and our company,” he said.
The transactions are subject to regulatory approval and other customary closing conditions and are expected to close by mid-2022.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance